Exscientia also has a really substantial collaboration [oncology and immunology/inflammation, up to $5.2 billion, launched in 2022] with Sanofi. What’s most exciting is, those are all future ...

Co-Administered With Atorvastatin, in Subjects with Hypertriglyceridemia 4 g/day 16 weeks NCT00435045 Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid-Ethyl Esters) in Recurrent ...

Sanofi has made a late entry to the radioligand party, paying 100 million euros ($110 million) upfront for global rights to a neuroendocrine tumor treatment that is nearing a filing for approval.

Sanofi Consumer Healthcare India Limited has been listed on the BSE and National Stock Exchange (NSE). SCHIL’s demerger from Sanofi India Limited, executed under the Scheme of Arrangement, was ...

Sanofi is following several of its big pharma industry peers into radiopharmaceuticals, striking a deal for a clinical-stage therapy now in discussion for a regulatory submission as a treatment ...

Involves transaction of at least 0.5% of the listed shares of a company. Sanofi Consumer Healthcare India Ltd share price was up by 4.03% from the previous closing price of ₹5,142.70.

Sept 16 (Reuters) - Sanofi (SASY.PA), opens new tab and partner AstraZeneca (AZN.L), opens new tab have received approval from the U.S. Food and Drug Administration for a manufacturing line for ...

Sanofi and Regeneron’s blockbuster drug Dupixent successfully treated patients with chronic spontaneous urticaria, an inflammatory skin disease, in a late-stage trial, the companies announced on ...

Sanofi was ordered to pay €280,000 (£236,539) and Mdm Martin's victory could lead to hundreds of other French challenges. According to French newspaper Le Monde, the court declared Sanofi ...

(Reuters) -Sanofi and partner AstraZeneca have received approval from the U.S. Food and Drug Administration for a manufacturing line for their preventive respiratory syncytial virus (RSV ...

Sanofi has temporarily stopped distributing and selling its flu shots in China out of concerns of waning potency. A Sanofi spokesperson confirmed the halt to Fierce Pharma. Supplies of the French ...